Maternal serum alphafetoprotein in pregnancy and the prevention of birth defect.
- 17 May 1980
- Vol. 280 (6225) , 1199-1202
- https://doi.org/10.1136/bmj.280.6225.1199
Abstract
No abstract availableThis publication has 34 references indexed in Scilit:
- POSSIBLE PREVENTION OF NEURAL-TUBE DEFECTS BY PERICONCEPTIONAL VITAMIN SUPPLEMENTATIONThe Lancet, 1980
- RAISED MATERNAL SERUM-ALPHA-FETOPROTEIN LEVELS AND SPONTANEOUS FETOMATERNAL TRANSFUSIONThe Lancet, 1979
- Regional organisation of neonatal intensive care in the North-westBMJ, 1979
- THE RELATION BETWEEN MATERNAL SERUM ALPHA‐FETOPROTEIN LEVELS AND FETOMATERNAL HAEMORRHAGEBJOG: An International Journal of Obstetrics and Gynaecology, 1979
- Combined use of alphafetoprotein and amniotic fluid cell morphology in early prenatal diagnosis of fetal abnormalities.Journal of Medical Genetics, 1978
- AVOIDANCE OF ANENCEPHALIC AND SPINA BIFIDA BIRTHS BY MATERNAL SERUM-ALPHAFETOPROTEIN SCREENINGThe Lancet, 1978
- ABCs of Perinatal MedicinePublished by Wiley ,1978
- MATERNAL SERUM ALPHA‐FETOPROTEIN AND SPONTANEOUS ABORTIONBJOG: An International Journal of Obstetrics and Gynaecology, 1977
- EARLY TERMINATION OF ANENCEPHALIC PREGNANCY AFTER DETECTION BY RAISED ALPHA-FETOPROTEIN LEVELSThe Lancet, 1973
- EARLY PRENATAL DIAGNOSIS OF ANENCEPHALYThe Lancet, 1972